DUBLIN--(BUSINESS WIRE)--The "Global Chronic Kidney Disease Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The research provides insights into Chronic Kidney Disease epidemiology, Chronic Kidney Disease diagnosed patients, and Chronic Kidney Disease treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Chronic Kidney Disease derived from epidemiological analysis, patients diagnosed with Chronic Kidney Disease, and patients treated with a drug therapy.
The research study helps executives estimate Chronic Kidney Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Chronic Kidney Disease prevalence, Chronic Kidney Disease diagnosis rate, and Chronic Kidney Disease treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.
For more information about this report visit https://www.researchandmarkets.com/research/brwnl7/global_chronic?w=4